Clinical Trials Directory

Trials / Unknown

UnknownNCT05268406

Evaluation of C-Scan in Identifying Subjects With Elevated Risk of Polyps in the Colon

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
800 (estimated)
Sponsor
Check-Cap Ltd. · Industry
Sex
All
Age
50 Years – 75 Years
Healthy volunteers
Accepted

Summary

The purpose of the first part of the study (subgroup R\&D) is to demonstrate the safety and performance of the C-Scan system and to collect data in order to improve the analysis process. The purpose of the second part of the study (subgroup pre-pivotal) is to determine the ability of the C-Scan System to identify elevated risk subjects

Conditions

Interventions

TypeNameDescription
DEVICEC-Scan SystemSubjects will be provided with contrast agent and dietary fiber pills, and instructed to start intake approximately 48 hours prior to the planned C-Scan procedure start. C-Scan system intervention includes ingestion of the C-Scan Cap and attachment of the C-Scan track to the subject's lower back. The subject is required to keep the C-Scan Track attached to the lower back and to continue intake of contrast agent and dietary fiber pills until the C-Scan Cap's natural excretion. Standard of care optical colonoscopy will be performed within 60 days from the C-Scan Cap ingestion.

Timeline

Start date
2020-07-29
Primary completion
2023-05-31
Completion
2023-08-31
First posted
2022-03-07
Last updated
2022-12-08

Locations

10 sites across 1 country: Israel

Source: ClinicalTrials.gov record NCT05268406. Inclusion in this directory is not an endorsement.